NCT03612050

Brief Summary

This randomized, controlled trial evaluates the effectiveness of an adaptation of a well-established brief, structured existential psychotherapy (Meaning Centered Psychotherapy) specifically tailored to the needs of palliative care patients (MCP-PC). Terminally ill patients with cancer who have been hospitalized in a palliative care hospital will be randomly assigned to either MCP-PC or enhanced usual care. Patients will complete a very short battery of self-report measures before the 3-session intervention, and again 2 and 4 weeks later to determine whether treatment has bolstered spiritual and psychological well-being and improved quality of life.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2018

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 2, 2018

Completed
3.4 years until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

August 30, 2021

Status Verified

August 1, 2021

Enrollment Period

1.7 years

First QC Date

March 15, 2018

Last Update Submit

August 24, 2021

Conditions

Keywords

Palliative careDespairSpiritual well-being

Outcome Measures

Primary Outcomes (1)

  • Spiritual Well Being

    Overall spiritual well-being as measured through the self-report FACIT Spiritual Well Being scale

    Through study completion (approx 6 weeks)

Secondary Outcomes (4)

  • Hopelessness

    Through study completion (approx 6 weeks)

  • Acceptance of Death

    Through study completion (approx 6 weeks)

  • Health related Quality of life

    Through study completion (approx 6 weeks)

  • Desire for hastened death

    Through study completion (approx 6 weeks)

Study Arms (2)

Enhanced Usual Care

PLACEBO COMPARATOR

facilitate any clinical interventions

Behavioral: Meaning Centered Psychotherapy

Meaning Centered Psychotherapy

EXPERIMENTAL

raise patients' sense of meaning/purpose

Behavioral: Meaning Centered Psychotherapy

Interventions

Manualized, 3-session existential psychotherapy (30-45 minutes/session) with an optional 4th "booster" session. Content focuses on enhancing patients sense of meaning and purpose in life.

Enhanced Usual CareMeaning Centered Psychotherapy

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Terminal illness with life expectancy of less than 6 months; hospitalized at a palliative care facility in Bronx NY, English speaking

You may not qualify if:

  • Cognitive impairment or severe psychiatric symptoms that preclude informed consent or participation in treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Rosenfeld B, Saracino R, Tobias K, Masterson M, Pessin H, Applebaum A, Brescia R, Breitbart W. Adapting Meaning-Centered Psychotherapy for the palliative care setting: Results of a pilot study. Palliat Med. 2017 Feb;31(2):140-146. doi: 10.1177/0269216316651570. Epub 2016 Jul 21.

    PMID: 27435603BACKGROUND

Study Officials

  • Barry Rosenfeld, PhD

    Fordham University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Barry D Rosenfeld, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2018

First Posted

August 2, 2018

Study Start

January 1, 2022

Primary Completion

September 30, 2023

Study Completion

December 31, 2023

Last Updated

August 30, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will share

Data will be made available upon request following completion of the study.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
One year after completion of data collection.
Access Criteria
Affiliation with medical or university-based research institute